1. Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapy Area Unit, GlaxoSmithKline, King of Prussia, Pennsylvania;
2. University of Bristol, Bristol, Avon, United Kingdom;
3. Laboratory Animal Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania;
4. Statistical Consulting Group, GlaxoSmithKline, King of Prussia, Pennsylvania;
5. Preclinical and Translational Imaging, GlaxoSmithKline, King of Prussia, Pennsylvania